BACKGROUND: To evaluate the diagnostic accuracy of activin A alone or in a multi-marker panel for the prediction of ectopic pregnancy (EP). METHODS: A retrospective analysis was performed on a cohort of 289 women who presented to the emergency department (ED) with vaginal bleeding and/or abdominal pain/cramping and were diagnosed with EP, spontaneous abortion, or viable intrauterine pregnancy. Serum progesterone, hCG, and activin A concentrations were measured on the samples obtained in the ED. Statistical analysis was performed to determine the clinical utility of these biomarkers as single measurement and as a multi-marker panel test for ectopic pregnancy. Women ≥18 y with vaginal bleeding or abdominal pain/cramping. RESULTS: Progesterone (<10 ng/ml), hCG (<6,699 IU/l), and activin A (<0.26 ng/ml) cutoffs were optimized by ROC analysis. These demonstrated sensitivities of 62.9%, 74.2%, and 59.6%, and specificities of 60.5%, and 63.0%, and 61.0% respectively for detecting EP. The multi-marker panel utilizing all three biomarkers had a sensitivity of 70% and specificity of 69%. CONCLUSION: Serum activin A cannot be used as a single measurement or in a multi-marker panel with progesterone and hCG to predict EP. Copyright Â
BACKGROUND: To evaluate the diagnostic accuracy of activin A alone or in a multi-marker panel for the prediction of ectopic pregnancy (EP). METHODS: A retrospective analysis was performed on a cohort of 289 women who presented to the emergency department (ED) with vaginal bleeding and/or abdominal pain/cramping and were diagnosed with EP, spontaneous abortion, or viable intrauterine pregnancy. Serum progesterone, hCG, and activin A concentrations were measured on the samples obtained in the ED. Statistical analysis was performed to determine the clinical utility of these biomarkers as single measurement and as a multi-marker panel test for ectopic pregnancy. Women ≥18 y with vaginal bleeding or abdominal pain/cramping. RESULTS:Progesterone (<10 ng/ml), hCG (<6,699 IU/l), and activin A (<0.26 ng/ml) cutoffs were optimized by ROC analysis. These demonstrated sensitivities of 62.9%, 74.2%, and 59.6%, and specificities of 60.5%, and 63.0%, and 61.0% respectively for detecting EP. The multi-marker panel utilizing all three biomarkers had a sensitivity of 70% and specificity of 69%. CONCLUSION: Serum activin A cannot be used as a single measurement or in a multi-marker panel with progesterone and hCG to predict EP. Copyright Â
Authors: Suneeta Senapati; Mary D Sammel; Samantha F Butts; Peter Takacs; Karine Chung; Kurt T Barnhart Journal: Fertil Steril Date: 2016-10-26 Impact factor: 7.329
Authors: Zhen Zhao; Qiuhong Zhao; Joshua Warrick; Christina M Lockwood; Alison Woodworth; Kelle H Moley; Ann M Gronowski Journal: Clin Chem Date: 2012-03-06 Impact factor: 8.327
Authors: Maya Al-Memar; Shabnam Bobdiwala; Mayank Madhra; Srdjan Saso; Bavo De Cock; Ben Van Calster; Jeremy K Brown; Faizah Mukri; Cecilia Bottomley; Aris Papageorghiou; Dirk Timmerman; Andrew W Horne; Tom Bourne Journal: Australas J Ultrasound Med Date: 2018-04-25
Authors: A Freis; J Schlegel; R J Kuon; A Doster; J Jauckus; T Strowitzki; A Germeyer Journal: Reprod Biol Endocrinol Date: 2017-11-02 Impact factor: 5.211